PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS

• Guillermo Garcia-Manero,
• Lewis Silverman,
• Lucy Yan,
• Wolfgang Dummer

Affiliations

Guillermo Garcia-Manero

1 University of Texas, MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine, Houston, United States

Lewis Silverman

2 Icahn School of Medicine at Mount Sinai (ISMMS) - The Derald H. Ruttenberg Treatment Center, Hematology-Oncology, New York City, United States

Lucy Yan

3 Rigel Pharmaceuticals, Inc., South San Francisco, United States

Wolfgang Dummer

3 Rigel Pharmaceuticals, Inc., South San Francisco, United States